Stevens Christopher James
Chief Operating Officer
Stevens Christopher James has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Stevens Christopher James is listed as Chief Operating Officer at ROCKET PHARMACEUTICALS, INC. Inside the rolling window, Stevens Christopher James reported no open-market purchases and 1 open-market sale totaling $128K in RCKT.
Companies traded
Other insiders at RCKT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$128K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Stevens Christopher James made?
Stevens Christopher James has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Stevens Christopher James trade?
Stevens Christopher James has filed SEC Form 4 disclosures for 1 company, including RCKT.
When was Stevens Christopher James's most recent SEC Form 4 filing?
Stevens Christopher James's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Stevens Christopher James's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Stevens Christopher James is listed as Chief Operating Officer.
What is Stevens Christopher James's total buy and sell value in the current window?
Inside the rolling retention window, Stevens Christopher James bought $0 and sold $128K based on SEC Form 4 filings.
What was Stevens Christopher James's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 36,658 RCKT shares on 2026-08-11, worth $128K, per SEC Form 4 filings.